Cancer hospital, Biotechnical research, commercial
Sotio LLC
SOTIO Biotech Inc., a member of the PPF Group, is based in Boston, MA, and is dedicated to advancing the development of innovative cancer immunotherapies. With a robust pipeline featuring both internally developed and in-licensed therapies, the company is committed to enhancing the safety and efficacy of treatments for solid tumors through rigorous clinical development.
The firm's diverse portfolio includes advanced drug candidates in areas such as antibody-drug conjugates and cell therapies, leveraging cutting-edge technologies like immunocytokines and BOXR. SOTIO's strategic vision focuses on transforming compelling scientific discoveries into therapeutic reality, aimed at improving patient outcomes in oncology. Generated from the website
